PrLZ increases prostate cancer docetaxel resistance by inhibiting LKB1/AMPK-mediated autophagy. [electronic resource]
Producer: 20181119Description: 109-123 p. digitalISSN:- 1838-7640
- AMP-Activated Protein Kinase Kinases
- AMP-Activated Protein Kinases -- genetics
- Animals
- Apoptosis -- drug effects
- Autophagy -- drug effects
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Docetaxel
- Flow Cytometry
- Humans
- Immunohistochemistry
- Immunoprecipitation
- Male
- Mice
- Mice, Nude
- Neoplasm Proteins -- genetics
- Prostatic Neoplasms -- drug therapy
- Protein Serine-Threonine Kinases -- genetics
- Real-Time Polymerase Chain Reaction
- Signal Transduction -- drug effects
- Taxoids -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.